Patent application number | Description | Published |
20080281151 | PULMONARY PLEURAL STABILIZER - A pulmonary pleural stabilizer may be utilized to hold the visceral pleura of the lung during surgical procedures involving accessing the lung or lungs of a patient directly through the lung and not the native airways. The device allows the lung to be opened while another device is inserted and sealed to the lung. | 11-13-2008 |
20080281295 | VISCERAL PLEURA RING CONNECTOR - A visceral pleura ring connector that may be utilized to anchor and seal the visceral pleura to a conduit or other device entering the lung from a non-native airway. The visceral pleura ring connector may be positioned around the visceral pleura and an insertion device and seal them together without having to make any holes in the pleura. The visceral pleura ring connector may be utilized with a pulmonary pleural stabilizer to hold the visceral pleura of the lung during surgical procedures involving accessing the lung or lungs of a patient directly through the lung and not the native airways. | 11-13-2008 |
20080281433 | METHODS AND DEVICES TO CREATE A CHEMICALLY AND/OR MECHANICALLY LOCALIZED PLEURODESIS - A localized pleurodesis for lung devices created utilizing a combination of a mechanical component and a chemical component. The chemical component is utilized to create an acute adhesion between the visceral pleural membrane and parietal pleural membrane while the mechanical component is utilized to create a chronic adhesion. | 11-13-2008 |
20080283065 | METHODS AND DEVICES TO MAINTAIN PATENCY OF A LUMEN IN PARENCHYMAL TISSUE OF THE LUNG - A mechanical device and/or chemical process is utilized to maintain luminal patency in conduits or other devices implanted in the lung or lungs of a patient. The mechanical device and/or chemical process ensures that air flows freely through a conduit implanted through an anastomosis into a lung. The device is suitable for use in conjunction with ventilation bypass treatments for chronic obstructive pulmonary disease. | 11-20-2008 |
20080287878 | PULMONARY VISCERAL PLEURA ANASTOMOSIS REINFORCEMENT - A pulmonary visceral pleura anastomosis reinforcement device may be positioned in proximity to a pulmonary pleural stabilizer or conduit to be inserted into a lung. The reinforcement device provides structural reinforcement and aids in preventing damage to the visceral pleura during insertion of a conduit or other device into the lung. | 11-20-2008 |
20080287973 | VARIABLE PARIETAL/VISCERAL PLEURAL COUPLING - A variable parietal/visceral pleural coupling may be utilized to create an air-tight seal in the pleural space between the parietal and visceral pleura. This coupling may be utilized to create a seal for other implantable devices. | 11-20-2008 |
20090205641 | PNEUMOSTOMA MANAGEMENT DEVICE AND METHOD FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A pneumostoma management device for maintaining the patency of a pneumostoma while controlling the flow of gases and discharge through the pneumostoma. The pneumostoma management device includes a bulb connected to a tube which enters the pneumostoma. A flow control device regulates air flow in and out of the pneumostoma via the tube. A hydrophobic filter traps discharge in the bulb while allowing gases to escape. | 08-20-2009 |
20090205643 | ACCELERATED TWO-PHASE SURGICAL PROCEDURE FOR CREATING A PNEUMOSTOMA TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE - An accelerated two-phase surgical procedure is disclosed for creating a pneumostoma to treat chronic obstructive pulmonary disease. The first phase includes creation of a localized pleurodesis. The localized pleurodesis is created using chemical agents and/or mechanical fasteners to secure the visceral membrane to the pleural membrane. The second phase includes introduction of a surgical instrument into the lung via the pleurodesis to create the pneumostoma. The first and second phases are performed as parts of a single surgical procedure. The formation of a stable pleurodesis is to prevent pneumothorax during the procedure. | 08-20-2009 |
20090205644 | PNEUMOSTOMA MANAGEMENT SYSTEM FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A pneumostoma management system for maintaining the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management system includes a two-part pneumostoma management device and associated insertion and removal tools. The pneumostoma management device includes a pneumostoma vent and a chest mount for positioning and securing the vent into a pneumostoma. The pneumostoma vent includes a hydrophobic filter and/or a one-way valve. | 08-20-2009 |
20090205645 | PNEUMOSTOMA MANAGEMENT METHOD FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A method for maintaining the patency of a pneumostoma while controlling the flow of material through the pneumostoma. A pneumostoma management system includes a two-part pneumostoma management device and associated insertion and removal tools. The pneumostoma management device includes a pneumostoma vent and a chest mount for positioning and securing the vent into a pneumostoma. To use the system, the chest is first cleaned and the chest mount secured to the chest adjacent the pneumostoma. The pneumostoma vent is then inserted into the pneumostoma through an aperture in the chest mount until it is engaged and secured by a coupling of the chest mount. The pneumostoma vent may be replaced periodically such as daily. The chest mount may be changed less frequently such as weekly. | 08-20-2009 |
20090205646 | FLEXIBLE PNEUMOSTOMA MANAGEMENT SYSTEM AND METHODS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A flexible pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management device includes a pneumostoma vent having a tube which enters the pneumostoma to allow gases to escape the lung, a flange and a filter/valve to control flow of materials through the tube. The flange is a thin flexible patch which conforms and attaches to the chest of the patient. The flange secures the tube in position in the pneumostoma. | 08-20-2009 |
20090205647 | PNEUMOSTOMA MANAGEMENT SYSTEM HAVING A COSMETIC AND/OR PROTECTIVE COVER - A pneumostoma management system which includes a pneumostoma management device and a cover. The pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management device includes a hydrophobic filter and/or a one-way filter. The cover serves to protect the pneumostoma management device and/or provide a cosmetic skin to make the pneumostoma management device more acceptable to the patient and thereby encourage patient compliance with a pneumostoma treatment regimen. | 08-20-2009 |
20090205648 | PNEUMOSTOMA MANAGEMENT SYSTEM WITH SECRETION MANAGEMENT FEATURES FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A flexible pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management device includes a pneumostoma vent having a tube which enters the pneumostoma to allow gases to escape the lung, a flange and a filter/valve to control flow of materials through the tube. The flange is a thin flexible patch which conforms and attaches to the chest of the patient. The flange secures the tube in position in the pneumostoma. The device has features to control secretions from the pneumostoma. The secretion management features include, ridges, pores, absorbent materials, and combinations thereof. | 08-20-2009 |
20090205649 | MULTI-LAYER PNEUMOSTOMA MANAGEMENT SYSTEM AND METHODS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A flexible pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management device includes a pneumostoma vent having a tube which enters the pneumostoma to allow gases to escape the lung, a flange and a filter/valve to control flow of materials through the tube. The flange is a thin flexible patch comprises of multiple thin layers of materials and which conforms and attaches to the chest of the patient. The flange includes a filter, a protective outer layer and an inner hydrocolloid layer. The flange secures the tube in position in the pneumostoma. | 08-20-2009 |
20090205650 | VARIABLE LENGTH PNEUMOSTOMA MANAGEMENT SYSTEM FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A flexible pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management device includes flange attaches to the chest of the patient to secure the device in position. The pneumostoma management device also includes a tube which enters the pneumostoma to allow gases to escape the lung. The length of the tube is selected to match the dimensions of the pneumostoma of a patient. In order to manufacture devices having different tube lengths, the tube is formed at a longer length than required, cut to size and tipped. The tube may be formed by molding or extrusion. | 08-20-2009 |
20090205651 | ONE-PIECE PNEUMOSTOMA MANAGEMENT SYSTEM AND METHODS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A flexible pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management device includes a pneumostoma vent having a tube which enters the pneumostoma to allow gases to escape the lung, a flange and a filter/valve to control flow of materials through the tube. The flange is a thin flexible patch which conforms and attaches to the chest of the patient. The flange secures the tube in position in the pneumostoma. The flange is formed in one piece with the tube. | 08-20-2009 |
20090205658 | DEVICES AND METHODS FOR DELIVERY OF A THERAPEUTIC AGENT THROUGH A PNEUMOSTOMA - A pneumostoma management system includes a pneumostoma management device for maintaining the patency of a pneumostoma and a drug delivery device for pneumostoma care. The drug delivery device includes a therapeutic agent dispenser for supplying a therapeutic agent and a propellant at positive pressure, a tube for entering the pneumostoma and a limiting device for limiting the depth of insertion of the tube into a pneumostoma. The drug delivery device may be used to introduce therapeutic agents into the pneumostoma for direct treatment of the pneumostoma, treatment of the lung by way of collateral ventilation, and/or treatment of non-lung tissues by diffusion into the bloodstream. | 08-20-2009 |
20090205665 | METHODS AND DEVICES FOR FOLLOW-UP CARE AND TREATMENT OF A PNEUMOSTOMA - A pneumostoma assessment and treatment system includes methods and devices for aftercare of a pneumostoma and for additional patient care utilizing a pneumostoma. The system utilizes a number of modalities to assess the health and functionality of the pneumostoma, the lungs and/or the patient as a whole. In response to an assessment of the health and functionality of the pneumostoma, lungs and patient, the tissues of pneumostoma may be treated with a treatment device and utilizing one or more different modalities to preserve or enhance the health and function of the pneumostoma and/or treat other conditions of the patient. | 08-20-2009 |
20090209856 | TWO-PHASE SURGICAL PROCEDURE FOR CREATING A PNEUMOSTOMA TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A two-phase surgical procedure is disclosed for creating a pneumostoma to treat chronic obstructive pulmonary disease The first phase is a procedure to induce creation of a localized pleurodesis and is preferably performed as an outpatient procedure. The second phase is a procedure to introduce a surgical instrument into the lung via the pleurodesis to create the pneumostoma. An interval of about one of more days between the first and second phases allows the formation of a stable pleurodesis to prevent pneumothorax during the procedure. | 08-20-2009 |
20090209906 | SELF-SEALING DEVICE AND METHOD FOR DELIVERY OF A THERAPEUTIC AGENT THROUGH A PNEUMOSTOMA - A pneumostoma management system includes a pneumostoma management device for maintaining the patency of a pneumostoma and a drug delivery device for pneumostoma care. The drug delivery device may be used to introduce therapeutic agents into the pneumostoma for direct treatment of the pneumostoma, treatment of the lung by way of collateral ventilation, and/or treatment of non-lung tissues by diffusion into the bloodstream. The drug delivery device includes a therapeutic agent dispenser for supplying a therapeutic agent and a propellant at positive pressure, an outlet and a connector for correctly positioning the outlet relative to a pneumostoma management device. The drug delivery device includes a self-centering and self-sealing connector for engaging the pneumostoma management device. | 08-20-2009 |
20090209909 | PERCUTANEOUS SINGLE-PHASE SURGICAL PROCEDURE FOR CREATING A PNEUMOSTOMA TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A percutaneous single-phase surgical procedure is disclosed for creating a pneumostoma to treat chronic obstructive pulmonary disease. A pneumostomy instrument is introduced percutaneously through the thoracic wall, parietal membrane, visceral membrane and into the parenchymal tissue of the lung. The pneumostomy instrument crosses the pleural cavity between the parietal membrane and visceral membrane there being no pleurodesis between the membranes prior to passage of the pneumostomy instrument. A pneumoplasty device at the distal end of the pneumostomy instrument displaces and engages the parenchymal tissue of the lung and the pneumostomy instrument is used to secure the lung and visceral membrane in contact with the parietal membrane and chest wall. The pneumostomy instrument is left in place while a pneumostoma tract heals and pleurodesis occurs between the pleural membranes surrounding the pneumostomy instrument. | 08-20-2009 |
20090209917 | ASPIRATOR FOR PNEUMOSTOMA MANAGEMENT - A pneumostoma management system includes a pneumostoma management device for maintaining the patency of a pneumostoma while controlling the flow of material through the pneumostoma and a pneumostoma aspirator for pneumostoma care. The pneumostoma aspirator includes a bulb or syringe for applying positive or negative pressure, a tube for entering the pneumostoma and a limiting device for limiting the depth of insertion of the tube into a pneumostoma. The pneumostoma aspirator may also be used to introduce irrigation fluid into the pneumostoma and/or remove irrigation fluid and discharge from the pneumostoma. | 08-20-2009 |
20090209924 | ENHANCED PNEUMOSTOMA MANAGEMENT DEVICE AND METHODS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A partially-implantable pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. A tube of the pneumostoma management device is placed through the chest wall into the lung. The tube comprises a plurality of holes in the distal end to allow the entry of gases and non-gaseous discharge from the lung. A contact surface prevents over-insertion of the tube while releasably securing the device to the chest of the patient. The contact surface has features to reduce irritation of the skin of the chest. | 08-20-2009 |
20090209936 | ASPIRATOR AND METHOD FOR PNEUMOSTOMA MANAGEMENT - A method for treating a pneumostoma by applying suction to the pneumostoma in order to remove solid or liquid discharge. A pneumostoma aspirator including a bulb or syringe is used to apply negative pressure to a tube which enters the pneumostoma. The pneumostoma aspirator may be used in conjunction with a pneumostoma management device. Alternatively, the pneumostoma aspirator may be used after the pneumostoma management device has been removed. The pneumostoma aspirator may also be used to introduce irrigation fluid into the pneumostoma and/or remove irrigation fluid and discharge from the pneumostoma. | 08-20-2009 |
20090209970 | SINGLE-PHASE SURGICAL PROCEDURE FOR CREATING A PNEUMOSTOMA TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A single-phase surgical procedure is disclosed for creating a pneumostoma to treat chronic obstructive pulmonary disease. In a single-phase technique the pleurodesis is formed at the same time as the pneumostoma and does not require a separate step. The thoracic cavity is accessed to visualize the lung, the pneumostomy catheter is inserted into the lung and then the lung is secured to the channel through the chest wall creating a sealed anastomosis which matures into a pleurodesis after the procedure. | 08-20-2009 |
20090209971 | SURGICAL INSTRUMENTS FOR CREATING A PNEUMOSTOMA AND TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE - Surgical instruments and techniques are provided for creating a pneumostoma through the chest wall into the lung of a patient. The pneumostomy instruments and techniques may be used to create a pneumostoma which allows gases to escape from the lung through the chest wall and thereby treat chronic obstructive pulmonary disease. | 08-20-2009 |
20090318904 | Devices and methods for maintaining collateral channels in tissue - The devices and methods of placement of such devices disclosed herein are directed to altering gaseous flow within a lung to improve the expiration cycle of, for instance, an individual having Chronic Obstructive Pulmonary Disease. More particularly, these devices produce and maintain collateral openings or channels through the airway wall so that oxygen depleted/carbon dioxide rich air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs. The medical kits disclosed herein are also directed to produce and maintain collateral openings through airway walls. | 12-24-2009 |
20100129420 | METHODS AND DEVICES TO ACCELERATE WOUND HEALING IN THORACIC ANASTOMOSIS APPLICATIONS - A long term oxygen therapy system having an oxygen supply directly linked with a patient's lung or lungs may be utilized to more efficiently treat hypoxia caused by chronic obstructive pulmonary disease such as emphysema and chronic bronchitis. The system includes an oxygen source, one or more valves and fluid carrying conduits. The fluid carrying conduits link the oxygen source to diseased sites within the patient's lungs. A collateral ventilation bypass trap system directly linked with a patient's lung or lungs may be utilized to increase the expiratory flow from the diseased lung or lungs, thereby treating another aspect of chronic obstructive pulmonary disease. The system includes a trap, a filter/one-way valve and an air carrying conduit. In various embodiments, the system may be intrathoracic, extrathoracic or a combination thereof A pulmonary decompression device may also be utilized to remove trapped air in the lung or lungs, thereby reducing the volume of diseased lung tissue. A lung reduction device may passively decompress the lung or lungs. In order for the system to be effective, an airtight seal between the parietal and visceral pleurae is required. Chemical pleurodesis is utilized for creating the seal and various devices and/or drugs, agents and/or compounds may be utilized to accelerate wound healing in thoracic anastomosis applications. | 05-27-2010 |
20100147294 | DEVICES AND METHODS TO MAINTAIN THE PATENCY OF AN OPENING RELATIVE TO PARENCHYMAL TISSUE OF THE LUNG - A mechanical device and/or chemical process is utilized to maintain luminal patency in conduits or other devices implanted in the lung or lungs of a patient. The mechanical device and/or chemical process ensures that air flows freely through a conduit implanted through an anastomosis into a lung. The device is suitable for use in conjunction with ventilation bypass treatments for chronic obstructive pulmonary disease. | 06-17-2010 |
20100147295 | DEVICES AND METHODS TO CREATE AND MAINTAIN THE PATENCY OF AN OPENING RELATIVE TO PARENCHYMAL TISSUE OF THE LUNG - A mechanical device and/or chemical process is utilized to maintain luminal patency in conduits or other devices implanted in the lung or lungs of a patient. The mechanical device and/or chemical process ensures that air flows freely through a conduit implanted through an anastomosis into a lung. The device is suitable for use in conjunction with ventilation bypass treatments for chronic obstructive pulmonary disease. | 06-17-2010 |
20100170507 | PNEUMOSTOMA MANAGEMENT DEVICE WITH INTEGRATED PATENCY SENSOR AND METHOD - A flexible pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management device includes a pneumostoma vent having a tube which enters the pneumostoma to allow gases to escape the lung, a flange and a filter/valve to control flow of materials through the tube. The flange is a thin flexible patch comprises of multiple thin layers of materials and which conforms and attaches to the chest of the patient. The flange includes a filter, a protective outer layer and an inner hydrocolloid layer. The flange secures the tube in position in the pneumostoma. An indicator responsive to gases exiting the pneumostoma is integrated into the device and provides and external indicia of the patency and efficacy of the pneumostoma. | 07-08-2010 |
20100204707 | SURGICAL INSTRUMENTS FOR CREATING A PNEUMOSTOMA AND TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE - Surgical instruments and techniques are provided for creating a pneumostoma through the chest wall into the lung of a patient. The pneumostomy instruments and techniques may be used to create a pneumostoma which allows gases to escape from the lung through the chest wall and thereby treat chronic obstructive pulmonary disease. | 08-12-2010 |
20100286544 | METHODS AND DEVICES FOR ASSESSMENT OF PNEUMOSTOMA FUNCTION - A pneumostoma assessment and treatment system includes methods and devices for aftercare of a pneumostoma. In particular, methods and devices are provided for standardized monitoring and assessment of pneumostoma patency thereby facilitating the establishment of standards-based protocols for pneumostoma management. Methods of standardized pneumostoma patency assessment includes the use of devices for raising alveolar pressure to a controlled repeatable pressure above ambient while analyzing gas flow through the pneumostoma. In response to an assessment the functionality of the pneumostoma, the tissues of the pneumostoma may be treated with a treatment device utilizing one or more different modalities to preserve or enhance the health and function of the pneumostoma. | 11-11-2010 |
20110118669 | ENHANCED PNEUMOSTOMA MANAGEMENT DEVICE AND METHODS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A partially-implantable pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. A tube of the pneumostoma management device is placed through the chest wall into the lung. The tube comprises a plurality of holes in the distal end to allow the entry of gases and non-gaseous discharge from the lung. A contact surface prevents over-insertion of the tube while releasably securing the device to the chest of the patient. The contact surface has features to reduce irritation of the skin of the chest. The pneumostoma management device may provide a pharmaceutically active substance selected to maintain the patency of the pneumostoma. | 05-19-2011 |
20110137295 | PULMONARY DECOMPRESSION DEVICE FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A lung reduction device is provided for treating chronic obstructive pulmonary disease by utilizing the phenomenon of collateral ventilation to increase the expiratory flow from a diseased lung. The device is adapted to penetrate the outer pleura of the lung to access the most collaterally ventilated area of a lung to remove trapped air. A conduit of the lung reduction device is positioned within the parenchyma of the lung while the housing of the lung reduction device is secured to the patient's body external to the lung. The housing includes means for allowing air from the lung of the patient to vent to an area external of the lung and may include suitable means for allowing one-way airflow such as a check valve, a reed valve, needle valve, or any other suitable device. | 06-09-2011 |
20110180064 | METHODS AND DEVICES FOR FOLLOW-UP CARE AND TREATMENT OF A PNEUMSTOMA - A pneumostoma assessment and treatment system includes methods and devices for aftercare of a pneumostoma and for additional patient care utilizing a pneumostoma. The system utilizes a number of modalities to assess the health and functionality of the pneumostoma, the lungs and/or the patient as a whole. In response to an assessment of the health and functionality of the pneumostoma, lungs and patient, the tissues of pneumostoma may be treated with a treatment device and utilizing one or more different modalities to preserve or enhance the health and function of the pneumostoma and/or treat other conditions of the patient. Particular treatment modalities may be utilized to reduce tissue growth in and around the pneumostoma in order to prevent stenosis and maintain patency of the pneumostoma. | 07-28-2011 |
20110208167 | VENTILATION BYPASS SYSTEM FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE - The invention provides a ventilation bypass system for treating chronic obstructive pulmonary disease in a lung of a patient. The patient is provided with a surgically-created passage which passes through the thoracic wall, the parietal membrane and the visceral membrane into the lung. The parietal and visceral membranes are sealed surrounding the passage. The system includes a conduit which passes through the passage into the lung. At the distal end of the conduit there is an aperture for admitting gasses from the lung. At the proximal end of the conduit is a flange for securing the conduit to the chest of the patient and a gas venting device for venting gasses external to the patient. The gas venting device can include a filter, valve and/or trap. | 08-25-2011 |
20110251592 | DEVICES FOR MAINTAINING SURGICALLY CREATED OPENINGS - Devices and methods are directed to improving the gaseous exchange in a lung of an individual having, for instance, chronic obstructive pulmonary disease. More particularly, conduits may be deployed in the lung to maintain collateral openings (or channels) surgically created through airway walls. This tends to facilitate both the exchange of oxygen ultimately into the blood and decompress hyper-inflated lungs. The conduit includes a radially expandable center section having a first end, a second end, and a passageway extending from the first end to the second end. A control segment may be associated with the conduit to limit the degree of radial expansion. The conduit further includes a plurality of deflectable members extending from the ends of the center section. A tissue barrier may coaxially surround the conduit such that tissue ingrowth is prevented. The conduits may also include hold-down members and bioactive coatings that serve to prevent ejection of the conduit as well as prevent narrowing of the passageway due to tissue ingrowth. | 10-13-2011 |
20110306935 | SELF-SEALING DEVICE AND METHOD FOR DELIVERY OF A THERAPEUTIC AGENT THROUGH A PNEUMOSTOMA - A pneumostoma management system includes a pneumostoma management device for maintaining the patency of a pneumostoma and a drug delivery device for pneumostoma care. The drug delivery device may be used to introduce therapeutic agents into the pneumostoma for direct treatment of the pneumostoma, treatment of the lung by way of collateral ventilation, and/or treatment of non-lung tissues by diffusion into the bloodstream. The drug delivery device includes a therapeutic agent dispenser for supplying a therapeutic agent and a propellant at positive pressure, an outlet and a connector for correctly positioning the outlet relative to a pneumostoma management device. The drug delivery device includes a self-centering and self-sealing connector for engaging the pneumostoma management device. | 12-15-2011 |
20120102879 | PNEUMOSTOMA MANAGEMENT SYSTEM PACKAGING AND KITS - A flexible pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The device is provided to patients in a sterile tray. The tray is efficiently packaged in order to supply a patient's needs for a period of time. Auxiliary and/or diagnostic materials can also be provided as part of the kit. | 05-03-2012 |
20120103853 | PNEUMOSTOMA MANAGEMENT SYSTEM PACKAGING AND KITS - A flexible pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The device is provided to patients in a sterile tray. The tray is efficiently packaged in order to supply a patient's needs for a period of time. Auxiliary and/or diagnostic materials can also be provided as part of the kit. | 05-03-2012 |
20120277584 | TWO-PHASE SURGICAL PROCEDURE FOR CREATING A PNEUMOSTOMA TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A two-phase surgical procedure is disclosed for creating a pneumostoma to treat chronic obstructive pulmonary disease The first phase is a procedure to induce creation of a localized pleurodesis and is preferably performed as an outpatient procedure. The second phase is a procedure to introduce a surgical instrument into the lung via the pleurodesis to create the pneumostoma. An interval of about one of more days between the first and second phases allows the formation of a stable pleurodesis to prevent pneumothorax during the procedure. | 11-01-2012 |
20130072910 | METHODS AND DEVICES TO ACCELERATE WOUND HEALING IN THORACIC ANASTOMOSIS APPLICATIONS - A minimally invasive lung reduction device which overcomes the disadvantages associated with treating chronic obstructive pulmonary disease by utilizing the phenomenon of collateral ventilation to increase the expiratory flow from a diseased lung. The device also provides a means for assisting in or facilitating pulmonary decompression to compress the diseased area or area of the lung or lungs to a smaller volume. | 03-21-2013 |
20130218134 | FLEXIBLE PNEUMOSTOMA MANAGEMENT SYSTEM AND METHODS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A flexible pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management device includes a pneumostoma vent having a tube which enters the pneumostoma to allow gases to escape the lung, a flange and a filter/valve to control flow of materials through the tube. The flange is a thin flexible patch which conforms and attaches to the chest of the patient. The flange secures the tube in position in the pneumostoma. | 08-22-2013 |